Trial
NCT03251872
Olaparib for PAH: a Pilot Study
Early Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Laval University
Collaborators
—
Condition
Pulmonary Arterial Hypertension
Intervention
Olaparib
Why stopped
OPTION pilot trial merged with the new NCT03782818 - OPTION multicenter trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-26